The company’s new AI agent automates labor-intensive processes involved in trial document management.

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Mr. Pattana Promphat, Minister of Public Health presided as a witness at the ceremony announcing the collaboration between the Food and Drug Administration (FDA) and the Food Science and Technology ...

W X-ray Generators capable of driving a plurality of sources, simultaneously. OXFORD, CT, UNITED STATES, January 14, ...

HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the ...

Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes ...

Sirnaomics Ltd. ( (HK:2257)) has issued an announcement. Sirnaomics Ltd. has announced that its subsidiary Sirnaomics, Inc. has completed a Phase I clinical trial of its investigational cancer drug ...

The Centers for Medicare & Medicaid Services late last year introduced the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model to expand access to select ...

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

AUGUSTA, GA - January 14, 2026 - PRESSADVANTAGE - Azalea Hospitality today announced its comprehensive ticketing and ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...

HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the ...